RRAD

RRAD

Target · Small GTPase

RRAD RRAD, Ras related glycolysis inhibitor and calcium channel regulator · GTP-binding protein RAD

RRAD (Ras related glycolysis inhibitor and calcium channel regulator, also known as REM3 or RAD) is a small GTPase of the RGK family. It regulates L-type calcium channel activity in cardiomyocytes and acts as a brake on cardiac hypertrophy. Browse Assay Genie's current range of RRAD research reagents below, or read on for the biology behind the target.

Cell membrane proteinRGK family small GTPaseBiomarker of heart failure
308 aa
Protein length
~33 kDa
Molecular weight
16q22.1
Gene locus
RGK GTPase
Protein family
Target information

What is RRAD (RRAD, Ras related glycolysis inhibitor and calcium channel regulator)?

RRAD encodes GTP-binding protein RAD, a member of the small GTPase superfamily and the RGK family. Its best-described role is in the heart, where it may regulate basal voltage-dependent L-type Ca(2+) currents and may be required for beta-adrenergic augmentation of Ca(2+) influx in cardiomyocytes. In this way it is proposed to shape increases in heart rate and contractile force. Strong suppression of voltage-gated L-type Ca(2+) currents also suggests an important role in cardiac antiarrhythmia.

RRAD regulates trafficking of the voltage-dependent L-type calcium channel subunit alpha-1C to the cell membrane, and the protein is found at the cell membrane. It also inhibits cardiac hypertrophy through the calmodulin-dependent kinase II (CaMKII) pathway, by inhibiting phosphorylation and activation of CAMK2D. NCBI Gene annotation predicts GTP binding and calcium channel regulator activity, involvement in small GTPase-mediated signal transduction, and localisation to the T-tubule and plasma membrane. Mouse and rat both carry an Rrad ortholog, so the RRAD gene can be studied in common rodent models.

The gene was originally named Ras-related associated with diabetes, and the current HGNC name reflects a role as a glycolysis inhibitor and calcium channel regulator. RRAD is implicated in type 2 diabetes mellitus and is described as a biomarker of congestive heart failure. These links make the RRAD protein a useful subject for work on cardiac calcium handling, hypertrophy and metabolic disease.

Cardiac calcium signalling

RRAD may regulate L-type Ca(2+) currents and beta-adrenergic augmentation of Ca(2+) influx in cardiomyocytes, affecting heart rate and contractile force.

Cardiac hypertrophy research

RRAD inhibits cardiac hypertrophy through the CaMKII pathway by limiting phosphorylation and activation of CAMK2D.

Arrhythmia and heart failure

RRAD may support cardiac antiarrhythmia through suppression of L-type currents, and it is described as a biomarker of congestive heart failure.

Diabetes and metabolism

RRAD, originally named Ras-related associated with diabetes, is implicated in type 2 diabetes mellitus.

Background

RRAD frequently asked questions

What does RRAD do?

RRAD is an RGK family small GTPase that may regulate L-type Ca(2+) currents in cardiomyocytes. It controls trafficking of the alpha-1C channel subunit to the cell membrane and inhibits cardiac hypertrophy through the CaMKII pathway by blocking CAMK2D phosphorylation and activation.

What other names does RRAD go by?

RRAD is also called REM3 and RAD, and UniProt lists the protein as GTP-binding protein RAD. An earlier name was Ras-related associated with diabetes. The current HGNC name is Ras related glycolysis inhibitor and calcium channel regulator.

Is RRAD linked to disease, and is it conserved in rodents?

RRAD is implicated in type 2 diabetes mellitus and is described as a biomarker of congestive heart failure. Mouse and rat each have an Rrad ortholog; check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other RGK family GTPases, L-type calcium channel components and CaMKII pathway proteins that relate to RRAD biology.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P55042; product specifications from Assay Genie datasheets.

RRAD Product listing